🌟 99% Happy customers

📦 Same-day shipping on in-stock items

Catalog Number:
37714
CAS Number:
38821-49-7
Carbidopa monohidrato
Purity:
≥ 98% (ensayo, HPLC)
Synonym(s):
Ácido ( S )-3-(3,4-dihidroxifenil)-2-hidrazino-2-metilpropionico monohidrato
Documents
$26.44 /100 mg
Tamaño
Request Bulk Quote
Product Information

Conservar bajo gas inerte.

Synonyms
Ácido ( S )-3-(3,4-dihidroxifenil)-2-hidrazino-2-metilpropionico monohidrato
CAS Number
38821-49-7
Purity
≥ 98% (ensayo, HPLC)
Molecular Formula
C10H14N2O4 · H2O
Molecular Weight
244.25
MDL Number
MFCD00889211
PubChem ID
441291
Appearance
Polvo de color blanco a amarillo claro a cristalino.
Optical Rotation
[a]20D = -21,0 a -23,5 ° (C=1 en sol. AlCl 3 )
Conditions
Conservar entre 2 y 8 °C.
General Information
Synonyms
Ácido ( S )-3-(3,4-dihidroxifenil)-2-hidrazino-2-metilpropionico monohidrato
CAS Number
38821-49-7
Purity
≥ 98% (ensayo, HPLC)
Molecular Formula
C10H14N2O4 · H2O
Molecular Weight
244.25
MDL Number
MFCD00889211
PubChem ID
441291
Appearance
Polvo de color blanco a amarillo claro a cristalino.
Optical Rotation
[a]20D = -21,0 a -23,5 ° (C=1 en sol. AlCl 3 )
Conditions
Conservar entre 2 y 8 °C.
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
No
Antibiotic
No
DEA-regulated
No
Warnings
-
Applications

Carbidopa monohydrate is widely utilized in research focused on:

  • Parkinson's Disease Treatment: It is a key component in medications that help manage symptoms of Parkinson's disease by preventing the conversion of levodopa to dopamine outside the brain, enhancing its effectiveness.
  • Pharmaceutical Formulations: Used in combination with levodopa, it improves the bioavailability of the drug, allowing for lower doses and reduced side effects, making treatments more tolerable for patients.
  • Research on Neurotransmitter Regulation: Carbidopa monohydrate is employed in studies investigating the role of neurotransmitters in neurological disorders, providing insights into brain chemistry and potential new therapies.
  • Clinical Trials: It is frequently included in clinical trials aimed at developing new treatment protocols for movement disorders, helping to assess the efficacy and safety of new drug combinations.
  • Patient Compliance Improvement: By reducing the side effects associated with levodopa therapy, it enhances patient adherence to treatment regimens, which is crucial for managing chronic conditions effectively.

Citas